story of the week
Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Science (New York, N.Y.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients
Science 2021 Feb 05;371(6529)602-609, EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg, A Lahat, L Katz, K Adler, D Dick-Necula, S Raskin, N Bloch, D Rotin, L Anafi, C Avivi, J Melnichenko, Y Steinberg-Silman, R Mamtani, H Harati, N Asher, R Shapira-Frommer, T Brosh-Nissimov, Y Eshet, S Ben-Simon, O Ziv, MAW Khan, M Amit, NJ Ajami, I Barshack, J Schachter, JA Wargo, O Koren, G Markel, B BoursiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.